RA Capital Nexus Fund II, L.P., 10% Owner at AN2 Therapeutics, Inc. (ANTX), bought 1,777,778 shares at $9.00 ($16.0M) on 2023-08-18, disclosed to the SEC on 2023-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| JANX | BUY | 2023-07-21 | $12.3M | — | Filing → |
| DICE | BUY | 2023-03-30 | $29.6M | — | Filing → |
| ANTX | BUY | 2022-07-28 | $361K | — | Filing → |